Last quarter (Q4 2023), Astrana Health's total revenue was $353.04M, an increase of Infinity% from the same quarter last year. In Q4, Astrana Health's net income was $12.36M. See Astrana Health’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 1.30B	$ 1.39B	$ 1.14B	$ 773.91M	$ 682.23M	$ 555.41M
Cost of Revenue	$ 563.19M	$ 1.17B	$ -1.04B	$ -596.14M	$ 539.21M	$ 467.81M
Gross Profit	$ 508.60M	$ 214.96M	$ 1.14B	$ 160.26M	$ 143.01M	$ 87.60M
Operating Expense	$ 406.24M	$ 112.60M	$ 1.04B	$ 62.08M	$ 62.51M	$ 53.19M
Operating Income	$ 84.61M	$ 84.61M	$ 104.27M	$ 98.18M	$ 80.50M	$ 34.41M
Net Non Operating Interest Income Expense	$ -1.89M	$ -1.89M	$ -5.94M	$ -3.82M	$ -6.69M	$ -2.71M
Other Income Expense	$ 10.63M	$ 10.63M	$ 11.71M	$ 16.61M	$ 104.61M	$ -5.87M
Pretax Income	$ 89.84M	$ 89.84M	$ 86.62M	$ 77.75M	$ 178.43M	$ 25.84M
Tax Provision	$ 31.99M	$ 31.99M	$ 36.09M	$ 28.45M	$ 56.11M	$ 8.17M
Earnings From Equity Interest Net Of Tax	$ 5.58M	$ 5.58M	$ 5.62M	$ -2.11M	-	-
Net Income Common Stockholders	$ 62.21M	$ 60.72M	$ 49.05M	$ 73.86M	$ 37.87M	$ 14.12M
Basic EPS	-	-	-	-	$ 1.04	$ 0.41
Diluted EPS	-	-	-	-	$ 1.01	$ 0.39
Basic Average Shares	-	-	-	-	$ 36.53M	$ 34.71M
Diluted Average Shares	-	-	-	-	$ 37.45M	$ 36.40M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 969.43M	$ 1.28B	-	$ -534.07M	$ 601.72M	$ 521.00M
Net Income From Continuing And Discontinued Operation	$ 60.72M	$ 60.72M	$ 49.05M	$ 73.86M	$ 37.87M	$ 14.12M
Normalized Income	$ 73.39M	$ 88.72M	-	-	$ -30.72M	$ 15.48M
Interest Expense	-	-	-	-	$ 9.50M	$ 4.73M
EBIT	$ 105.94M	$ 105.94M	$ 94.54M	$ 83.14M	$ 187.93M	$ 30.57M
EBITDA	$ 124.75M	$ 124.75M	$ 113.02M	$ 101.74M	$ 206.28M	$ 48.85M

Currency in USD

Astrana Health Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing